B

    Bausch Health Companies Inc (BHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $6.36
    +0.04 (+0.55%)

    Market Cap: $2.36B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    73%(29/40)
    Avg Surprise
    +4.64%
    Streak
    2 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$1.19
    Range$1.01 - $1.33
    5 analysts
    EPS Revisions
    2
    0
    7d
    1
    2
    30d
    EPS Estimate Drift
    90d ago$1.24+4.3%
    60d ago$1.23+3.0%
    30d ago$1.28+7.5%
    7d ago$1.19-0.1%
    Current$1.19
    Revenue Consensus
    $2.7B
    Range$2.7B - $2.8B
    4 analysts
    Dec 31, 2026
    EPS Consensus$1.58
    Range$1.14 - $1.87
    6 analysts
    Revenue Consensus
    $3.1B
    Range$2.9B - $3.1B
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.58---
    Sep 26EST
    		-$1.19---
    Jun 26
    		$1.26$0.96+31.25%Beat+38.5%
    Mar 26
    		$0.78$0.69+13.04%Beat+27.9%
    Dec 25
    		$1.08$1.21-10.74%Miss-6.9%
    Sep 25
    		$1.16$1.06+9.43%Beat+2.7%
    Jun 25
    		$0.91$0.94-3.19%Miss-7.1%
    Mar 25
    		$0.61$0.85-28.24%Miss+3.4%
    Dec 24
    		$1.16$1.13+2.96%Beat+0.9%
    Sep 24
    		$1.13$1.02+10.78%Beat+9.7%
    Jun 24
    		$0.98$0.88+11.36%Beat+21.0%
    Mar 24
    		$0.59$0.72-18.06%Miss+11.3%
    Dec 23
    		$1.15$1.02+12.75%Beat+11.7%
    Sep 23
    		$1.03$0.92+11.96%Beat+35.5%
    Jun 23
    		$0.81$0.73+10.96%Beat+47.3%
    Mar 23
    		$0.53$0.68-22.06%Miss-26.4%
    Dec 22
    		$1.03$0.95+8.42%Beat-19.5%
    Sep 22
    		$0.76$0.78-2.56%Miss-33.9%
    Jun 22
    		$0.55$0.91-39.56%Miss-43.3%
    Mar 22
    		$0.72$1.03-30.10%Miss-29.4%
    Dec 21
    		$1.28$1.12+14.29%Beat-3.8%
    Sep 21
    		$1.15$1.06+8.49%Beat-12.2%
    Jun 21
    		$0.97$0.95+2.11%Beat+110.9%
    Mar 21
    		$1.02$0.95+7.37%Beat+14.6%
    Dec 20
    		$1.33$1.12+18.75%Beat+15.7%
    Sep 20
    		$1.31$1.04+25.96%Beat+8.3%
    Jun 20
    		$0.46$0.65-29.23%Miss-57.0%
    Mar 20
    		$0.89$0.88+1.14%Beat-13.6%
    Dec 19
    		$1.15$1.13+1.77%Beat+11.7%
    Sep 19
    		$1.21$1.09+11.01%Beat+5.2%
    Jun 19
    		$1.07$1.06+0.94%Beat+15.1%
    Mar 19
    		$1.03$0.86+19.77%Beat+17.0%
    Dec 18
    		$1.03$0.84+22.62%Beat+5.1%
    Sep 18
    		$1.15$0.86+33.72%Beat+10.6%
    Jun 18
    		$0.93$0.80+16.25%Beat-11.4%
    Mar 18
    		$0.88$0.60+46.67%Beat+12.8%
    Dec 17
    		$0.98$0.97+1.03%Beat-22.2%
    Sep 17
    		$1.04$0.89+16.85%Beat-32.9%
    Jun 17
    		$1.05$0.96+9.38%Beat-
    Mar 17
    		$0.78$0.82-4.88%Miss-
    Dec 16
    		$1.26$1.20+5.00%Beat-
    Sep 16
    		$1.55$1.76-11.93%Miss-

    Dividends

    Dividend Metrics

    Yield0.00%
    Annual/Share$0.00
    Payout Ratio0.00%
    No dividend payments in the selected period.
    View BHC's full dividend history

    Key Metrics

    Valuation
    P/E Ratio1.48EV/EBITDA10.41x
    Price/FCF1.67xFCF Yield60.05%
    Profitability
    Profit Margin-10.10%Operating Margin27.20%
    ROE43.60%ROIC4.46%
    Financial Health
    Debt/Equity-11.71xInterest Coverage0.52x
    Current Ratio1.44xQuick Ratio1.08x
    Trading Statistics
    Beta0.38Avg Volume3.80M
    52-Week High$8.0052-Week Low$4.33

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$6.60
    SMA 20$6.45
    SMA 50$5.56
    SMA 200$5.85
    EMA 10$6.46
    EMA 20$6.31
    EMA 50$5.87
    EMA 200$5.81

    MACD

    Line: 0.25Signal: 0.33Hist: -0.09

    ADX

    ADX: 34.2+DI: 27.0-DI: 19.9

    Aroon & PSAR

    Aroon Up20.0
    Aroon DownN/A
    PSAR$7.24

    Bollinger Bands

    Upper Band$6.96
    Lower Band$5.94
    %B Position1582%(Upper)
    Band Width0.40

    RSI (14-Day)

    Neutral
    53.9

    Momentum Oscillators

    Stoch %K26.7
    Stoch %D36.7
    Williams %R-70.4
    ROC (10d)-3.4%
    Momentum-0.23
    CCI (20d)-54.1
    MFI (14d)54.9

    Volatility Measures

    ATR (14d)$0.32(5.0%)
    StdDev (20d)0.26
    Hist Vol57.5%(High)

    Volume Flow

    VWAP$6.29
    OBV69.3M
    AD Line7.3M
    CMF (20d)-0.071

    Volume Metrics

    Avg Vol (20d)3.5M
    Vol Ratio0.7x
    VWMA (20d)$6.46

    Pivot Points

    R3$6.51
    R2$6.43
    R1$6.38
    Pivot Point$6.30
    S1$6.25
    S2$6.17
    S3$6.12

    Advanced Oscillators

    TSI18.40
    Ultimate Osc52.7
    KST265.14

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.85B$2.52B$2.80B$2.68B$2.53B$2.26B$2.56B$2.51B$2.40B$2.15B$2.41B$2.24B
    Cost of Revenue$772.00M$738.00M$798.00M$750.00M$764.00M$701.00M$727.00M$696.00M$719.00M$640.00M$705.00M$623.00M
    Gross Profit$2.08B$1.79B$2.00B$1.93B$1.77B$1.56B$1.83B$1.81B$1.68B$1.51B$1.70B$1.61B
    Operating Expenses$1.34B$2.74B$1.52B$1.31B$1.32B$1.28B$1.27B$1.50B$1.29B$1.23B$1.34B$1.60B
    R&D$173.00M$163.00M$161.00M$166.00M$159.00M$143.00M$163.00M$146.00M$156.00M$151.00M$152.00M$153.00M
    SG&A$907.00M$861.00M$882.00M$795.00M$894.00M$867.00M$820.00M$850.00M$832.00M$794.00M$766.00M$715.00M
    Operating Income$740.00M$-950,000,000$474.00M$619.00M$444.00M$276.00M$558.00M$318.00M$389.00M$281.00M$362.00M$14.00M
    Interest Income$11.00M$10.00M$9.00M$15.00M$13.00M$11.00M$9.00M$7.00M$8.00M$9.00M$7.00M$6.00M
    Interest Expense$396.00M$403.00M$416.00M$409.00M$287.00M$330.00M$337.00M$346.00M$338.00M$344.00M$362.00M$339.00M
    Income Before Tax$348.00M$-1,354,000,000$56.00M$218.00M$140.00M$-47,000,000$209.00M$-21,000,000$48.00M$-69,000,000$-7,000,000$-326,000,000
    Income Tax Expense$88.00M$77.00M$159.00M$37.00M$12.00M$39.00M$111.00M$71.00M$49.00M$8.00M$40.00M$56.00M
    Net Income$260.00M$-1,431,000,000$-103,000,000$181.00M$128.00M$-86,000,000$98.00M$-92,000,000$-1,000,000$-77,000,000$-47,000,000$-382,000,000
    EBITDA$1.03B$-649,000,000$777.00M$954.00M$782.00M$614.00M$879.00M$674.00M$730.00M$620.00M$714.00M$336.00M
    EBIT$733.00M$-961,000,000$463.00M$612.00M$414.00M$272.00M$537.00M$318.00M$378.00M$266.00M$348.00M$7.00M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BHC

    News

    Bausch Health Companies Inc (BHC) News, Articles, Events & Latest Updates

    Bausch Health Companies Inc. (BHC) has recently seen several positive developments, including an upgrade to a Zacks Rank #2 (Buy) due to strong earnings estimate revisions and robust Q2 2026 results that beat estimates. The company also announced the winners of its 2026 Gastrointestinal Health Scholars Program and the appointment of CEO Thomas J. Appio to the Bausch + Lomb Board. These factors have contributed to investor optimism and a significant rise in stock value.

    Stocktwits•8/22/26•
    Bullish

    What is Zacks Research's Estimate for TSE:BHC Q3 Earnings?

    Zacks Research has updated its Q3 2026 EPS estimate for Bausch Health Companies (TSE:BHC) to $1.44, a slight decrease from its previous forecast of $1.47. The firm also provided earnings estimates for several future quarters and full fiscal years. Despite the slight downward revision for Q3 2026, the company's shares are trading near a 12-month high, and analysts maintain a "Hold" rating on the stock.

    MarketBeat•8/21/26•
    Neutral

    Bausch Health Cos (NYSE:BHC) Insider Aimee Lenar Sells 36,827 Shares

    Bausch Health Cos (NYSE:BHC) insider Aimee Lenar sold 36,827 shares of the company's stock for approximately $258,894, reducing her ownership by 9.91%. This transaction was conducted under a Rule 10b5-1 trading plan. The company recently reported strong quarterly earnings, exceeding analyst estimates, but maintains a negative return on equity and net margin.

    MarketBeat•8/20/26•
    Neutral

    Bausch Health (BHC) insider sells 36,827 shares in plan trade

    Aimee J. Lenar, President, US Pharma of Bausch Health Companies Inc. (BHC), sold 36,827 common shares on August 19, 2026, at $7.03 per share. This transaction was conducted as an open-market sale under a Rule 10b5-1 trading plan adopted on May 21, 2026. Following the sale, Lenar directly holds 334,853 common shares.

    Stock Titan•8/20/26•
    Bearish

    FY2026 EPS Estimate for Bausch Health Cos Raised by Analyst

    Zacks Research has increased its FY2026 EPS estimate for Bausch Health Cos (NYSE:BHC) to $4.24 from $3.93, while maintaining a "Strong Sell" rating. This adjustment aligns with the current consensus forecast. The company recently exceeded earnings expectations, reporting an EPS of $1.26 against a consensus of $0.96 and revenue of $2.83 billion against an expected $2.59 billion.

    MarketBeat•8/20/26•
    Somewhat-Bullish

    Frequently Asked Questions About BHC

    Does BHC pay dividends?
    Bausch Health Companies Inc (BHC) has a dividend payment track record. See the BHC dividend history page for its current payment status, yield, and streaks.
    What is BHC's P/E ratio?
    Bausch Health Companies Inc has a price-to-earnings (P/E) ratio of 1.48.
    What is BHC's market cap?
    Bausch Health Companies Inc (BHC) has a market capitalization of $2.36B with a current stock price of $6.36.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In